<DOC>
	<DOCNO>NCT02291445</DOCNO>
	<brief_summary>This pilot study compare relative bioavailability two peppermint oil formulation , namely colon-targeted-delivery capsule ( Tempocol-ColoPulse® ) enteric-coated capsule ( Tempocol® ) . This study conduct part future multicenter randomize control trial ass therapeutic effect new peppermint oil formulation IBS patient .</brief_summary>
	<brief_title>Comparing 182mg Colon-targeted-delivery Peppermint Oil Capsule ( Tempocol-ColoPulse® ) 182mg Enteric-coated Peppermint Oil Capsule ( Tempocol® ) , Pharmacokinetic Study</brief_title>
	<detailed_description>Rationale : Peppermint oil show effective treatment IBS symptoms several meta-analyses . However , level evidence moderate peppermint oil remain relatively under-used IBS . Therefore investigator plan conduct multicenter randomize control trial investigate possible beneficial effect peppermint oil IBS . To improve efficacy reduce side effect , investigator aim study use new peppermint oil formulation ( Tempocol-ColoPulse® ) slowly release oil ( ileo- ) colonic region specifically . In order demonstrate difference pharmacokinetics , subsidize party , ZonMW , request additional pilot study ( describe present protocol ) investigator investigate surrogate marker local colon bioavailability , tolerability side effect new Tempocol-ColoPulse® . Study design : randomize , double blind , two-period , two-treatment crossover study wash period least 14 day . Intervention : All study volunteer receive single dose 182mg Tempocol-ColoPulse® Tempocol® , different test day . Nature extent burden risk associate participation , benefit group relatedness : Subjects may confront certain inconvenience minor risk . They require visit MUMC+ 5 time , screen two time per test day various non-invasive measurement ( questionnaire , blood pressure heart-rate measurement , urine fecal sampling , pregnancy test woman fertile age , general physical exam ) well minor invasive venous blood sampling , small haematoma occur . Total time investment +/- 30 hour , subject benefit participation .</detailed_description>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Abdominal Pain</mesh_term>
	<mesh_term>Colonic Diseases</mesh_term>
	<mesh_term>Visceral Pain</mesh_term>
	<mesh_term>Peppermint oil</mesh_term>
	<criteria>Based medical history previous examination , gastrointestinal complaint define Age 18 65 year BMI 18 25 kg/m2 weight least 50 kilogram Women fertile age ( &lt; 55 year old ) must use contraception postmenopausal least two year History severe chronic cardiovascular , respiratory , urogenital , gastrointestinal/ hepatic , hematological/immunologic , HEENT ( head , ears , eye , nose , throat ) , dermatological/connective tissue , musculoskeletal , metabolic/nutritional , endocrine , neurological/psychiatric disease , allergy , major surgery and/or laboratory assessment might limit participation completion study protocol Use medication , include vitamin iron supplementation , except oral contraceptive , within 14 day prior start study Administration investigational drug participation scientific intervention study may interfere study ( decided principle investigator ) , 180 day prior study Major abdominal surgery interfere gastrointestinal function ( uncomplicated appendectomy , cholecystectomy hysterectomy allow , surgery upon judgment principle investigator ) Dieting ( example lactosefree , glutenfree , caloricrestrictive , vegetarian vegan , macrobiotic diet ) Pregnancy , lactation High alcohol consumption ( &gt; 15 alcoholic consumption per week ) Smoking/ Using drug abuse Selfadmitted HIVpositive state Known allergic reaction peppermint High intake caffeine ( &gt; 8 cup coffee day )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2015</verification_date>
	<keyword>Peppermint oil</keyword>
	<keyword>Menthol</keyword>
	<keyword>Volatile oil</keyword>
	<keyword>Plant oil</keyword>
	<keyword>Visceral pain</keyword>
	<keyword>Abdominal pain</keyword>
	<keyword>Irritable bowel syndrome ( IBS )</keyword>
	<keyword>Colonic disease</keyword>
</DOC>